Mon panier

CelThera™ GMP GDT Cell Expansion Kit (Phenol Red-free)
DMF

  • Transfer Cap for Square Media Bottle (PCA-25021401) is available for convenient sterile transfer of media from the bottle to closed culture systems like cell culture bags via aseptic welding.
Avis des utilisateurs
Numéro de produit/spécification
Prix
Qté
GMP-GDTCM32-1L
$245.00
ETA of in-stock products:2 business days
Total des articles Montant du produit$ 0

Détails du produit

  • Cat. No.
    Components
    Size
    GMP-CM3102A
    CelThera™ GMP Immune Cell Expansion Medium (Phenol Red-free)
    1000 mL
    GMP-CM3101-1
    CelThera™ GMP T Cell Expansion Supplement
    7.25 mL
    GMP-CM31S3
    CelThera™ GMP Immune Cell Supplement D
    1.5 mL
  • Product Show

    Media PRODUCT SHOW
  • Product Details

    CelThera™ GMP GDT Cell Expansion Medium (Phenol Red-free) is a serum-free culture medium specifically developed to support human gamma delta T cell culture. It is a serum-free, animal origin-free T cell maintenance and expansion medium produced under GMP conditions.

    Compared to traditional culture media or xeno-free culture media, animal origin-free culture media can better reduce the risk of introducing potential pathogenic microorganisms during culture process, and improve batch-to-batch consistency.

  • Features

    1. Chemically Defined, animal origin-free (AOF), and exogenous growth factors free;
    2. Provide unique nutritional requirements that could supply a suitable growth environment for gamma delta T cells;
    3. Designed to support low-density seeding and high-density seeding of gamma delta T cell expansion;
    4. A better performance compared to other commercial products;
    5. Contains only recombinant proteins as components, no antibiotics added during manufacturing;
    6. Produced according to current GMP guidelines.
  • Storage

    CelThera™ GMP Immune Cell Expansion Medium (Phenol Red-free) is stable for 18 months when stored under 2-8°C, protect from light.
    CelThera™ GMP T Cell Expansion Supplement is stable for 24 months when stored under -20°C or below, protect from light.
    CelThera™ GMP Immune Cell Supplement D is stable for 30 months when stored under -20°C or below, protect from light.

  • Shipping

    Components may ship in separate packages with different temperature controls (dry ice or blue ice). Please inquire about the shipping cost. Inspect all parcels upon arrival.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Les clients ont également consulté

Affichage des données

  • Application Data

     Media APPLICATION DATA

    PBMCs were cultured with γδT Cell Expansion Medium (without human AB serum) for two weeks. The results of the cell expansion showed that γδT Cell Expansion Medium (ACROBio) can be comparable to the Competitor products. Notably, the total cells and γδ2T cells exhibit better expansion in ACRO's γδT Cell Expansion Medium.

  •  Media APPLICATION DATA

    PBMCs were cultured with γδT Cell Expansion Medium (without human AB serum) for two weeks. The cell viability results showed that γδT Cell Expansion Medium (ACROBio) can be comparable to Competitor products. Notably, the cells exhibit better cell viability in ACRO's γδT Cell Expansion Medium. The results of γδ2T proportion showed no significant difference.

  •  Media APPLICATION DATA

    PBMCs were cultured with γδT cell medium (with human AB serum) for two weeks. The results of the Cell expansion showed that γδT Cell Expansion Medium (ACROBio) can be comparable to the Competitor products. Notably, the total cells and γδ2T cells exhibit better expansion in γδT Cell Expansion Medium.

  •  Media APPLICATION DATA

    PBMCs were cultured with γδT cell medium (with human AB serum) for two weeks. The cell viability results showed that γδT Cell Expansion Medium (ACROBio) can be comparable to the Competitor γδT medium. Notably, the cells exhibit better cell viability in γδT Cell Expansion Medium (ACROBio) compared to competitor 1.

  • Large-scale Culture Verification

     Media LARGE-SCALE CULTURE VERIFICATION

    Starting with 9 million cryopreserved Peripheral Blood Mononuclear Cells (PBMCs) as seed cells, continuous feeding and expansion were performed beginning from a 3 ml volume. After 14 days, the culture expanded to 2*1000 ml, yielding over 6 billion cells.

Avis des utilisateurs
Publier un commentaire

Déclaration importante

  • MANUFACTURING SPECIFICATIONS

    ACROBiosystems GMP grade mediums are produced under a quality management system and in compliance with relevant guidelines: Ph. Eur General Chapter 5.2.12 Raw materials of biological origin for the production of cell-based and gene therapy medicinal products; USP <1043> Ancillary Materials for Cell, Gene, and Tissue-Engineered Products; ISO 20399: 2022(E), Biotechnology - Ancillary materials present during the production of cellular therapeutic products and gene therapy products.

    ACROBiosystems Quality Management System Contents:

    1. GMP-certified facility (compliance with FDA cGMP, EMA GMP, ICH, ISO9001/13485/MDSAP, and certified by third-party SGS, UL, and RX360)
    2. Animal origin-free materials, equipments, and facilities
    3. Materials sourced only from approved suppliers
    4. ISO 5 cleanrooms and automatic filling equipment
    5. Professional quality personnel and training programs
    6. Validated analytical testing methods in accordance with the ICH guidelines
    7. Safety Testing (Sterility, Mycoplasma, etc): compliant with USP, EP, etc
    8. In-depth stability studies
    9. Fully batch production and control records
    10. Equipment maintenance and calibration

    Request For Regulatory Support Files (RSF)  


    ACROBiosystems provide rigorous quality control tests (fully validated equipment, processes and test methods) on our GMP grade products to ensure that they meet stringent standards in terms of purity, safety, activity and inter-batch stability, and each bulk QC lot mainly contains the following specific information:

    1. pH
    2. Sterility (USP<71>; EP<2.6.1>)
    3. Osmolality
    4. Endotoxin (USP<86>; EP<2.6.32>)
    5. Functionality
    6. Mycoplasma (USP<63>; EP<2.6.7>)
    7. Batch-to-batch consistency


  • ACROBIOSYSTEMS - LEGAL NOTICES FOR GMP GRADE PRODUCTS

    1. PRODUCT USE RESTRICTIONS & PROHIBITIONS

    • 1.1 ACROBiosystems ("ACRO") GMP grade products ("Products") are designed for research, manufacturing use or ex vivo use.
    • 1.2 Products are NOT intended for diagnostic purposes or for direct or indirect administration into humans.
    • 1.3 Purchaser shall not market, distribute, or resell Products obtained from ACRO without ACRO's prior written consent.

    2. REVERSE ENGINEERING PROHIBITED & CONFIDENTIALITY

    • 2.1 Purchaser shall not reverse-engineer, decompile, disassemble, sequence, analyze via bioinformatics, or otherwise attempt to discover the structure, sequence, composition, construction, manufacturing process, or any trade secret embodied in the Products. Purchaser shall not permit any third party to undertake such activities.
    • 2.2 All specifications, data, and know-how related to the Products provided by ACRO are ACRO's confidential information and shall be protected accordingly.

    3. LIMITED WARRANTY & DISCLAIMERS

    • 3.1 ACRO warrants solely that Products will conform to their published specifications when used under normal, specified laboratory/manufacturing conditions and within their labeled expiration date. THIS IS THE ONLY WARRANTY PROVIDED.
    • 3.2 Purchaser assumes ALL risk and responsibility for:
      (a) Determining the suitability of Products for Purchaser's intended application(s).
      (b) Obtaining any necessary regulatory approvals or intellectual property licenses for Purchaser's use.
      (c) Compliance with all applicable laws, regulations (including but not limited to cGMP/GLP where claimed), and industry standards.
      (d) Conducting all necessary quality control, safety, efficacy, and validation testing of Products within Purchaser's process or final product.
      (e) Proper storage, handling, and use of Products according to ACRO's instructions.
    • 3.3 ACRO EXPRESSLY DISCLAIMS ALL OTHER WARRANTIES, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHERWISE, INCLUDING BUT NOT LIMITED TO: (A) WARRANTIES OF MERCHANTABILITY; (B) WARRANTIES OF FITNESS FOR A PARTICULAR PURPOSE; (C) WARRANTIES OF NON-INFRINGEMENT; AND (D) WARRANTIES ARISING FROM COURSE OF DEALING OR USAGE OF TRADE.

    4. LIMITATION OF LIABILITY

    • IN NO EVENT SHALL ACRO, ITS AFFILIATES, OR SUPPLIERS BE LIABLE FOR ANY OF THE FOLLOWING, HOWSOEVER ARISING (WHETHER IN CONTRACT, TORT (INCLUDING NEGLIGENCE), STRICT LIABILITY, STATUTE, OR OTHERWISE):
      (a) LOST PROFITS, LOST REVENUE, LOST SAVINGS, LOSS OF USE, LOSS OF DATA, BUSINESS INTERRUPTION, OR ANY OTHER INDIRECT, INCIDENTAL, SPECIAL, PUNITIVE, OR CONSEQUENTIAL DAMAGES.
      (b) ANY DIRECT DAMAGES, COSTS, OR EXPENSES EXCEEDING THE AMOUNT PAID BY PURCHASER FOR THE SPECIFIC PRODUCT(S) GIVING RISE TO THE CLAIM.
      (c) DAMAGES ARISING FROM: (i) MISUSE, ABUSE, OR UNAUTHORIZED MODIFICATION OF PRODUCTS; (ii) USE BEYOND THE EXPIRATION DATE; (iii) IMPROPER STORAGE OR HANDLING; (iv) ACCIDENTAL DAMAGE; (v) FAILURE TO CONDUCT ADEQUATE VALIDATION OR TESTING BY PURCHASER; (vi) INFRINGEMENT CLAIMS RELATED TO PURCHASER'S USE; OR (vii) THE COST OF PROCURING SUBSTITUTE GOODS OR SERVICES.
      (d) ANY PERSONAL INJURY, DEATH, OR DAMAGE TO TANGIBLE PROPERTY TO THE EXTENT PERMITTED BY LAW.

    5. END USER ACKNOWLEDGEMENT & COMPLIANCE

    • 5.1 By accepting, opening, or using the Products, the End User (Purchaser or its downstream recipient) agrees to be irrevocably bound by all terms herein.
    • 5.2 End User explicitly acknowledges the Products are NOT FOR HUMAN ADMINISTRATION and agrees not to use them in any in vivo human application, directly or indirectly.
    • 5.3 End Users unwilling to accept these terms must immediately: (a) cease all use; (b) notify ACRO or their supplier; and (c) return the unopened, unused Products.
    • 5.4 ACRO reserves the right to audit End User's compliance with these restrictions upon reasonable notice.

    ACRO has the right, at its sole discretion, to modify, add or remove any terms herein without notice to Purchaser and/or End User. Any changes to these terms are effective immediately following the updating of such changes on ACRO’s website or published specifications or product-related documents.

Progrès de frontière

 
Drug Candidate Licensing
More
  • Informations de base sur le produit
  • Détails du produit
  • Les clients ont également consulté
  • Affichage des données
  • Avis des utilisateurs
  • Déclaration importante